A Randomized, Double-Blind, Phase II, Efficacy and Safet

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 (ASP9785) vs. Bicalutamide in Castrate Men with Metastatic Prostate Cancer
StatusFinished
Effective start/end date2/27/127/20/15

Funding

  • Astellas Pharma US, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.